Drugs that contain Pazopanib Hydrochloride

1. Votrient patents expiration

Drug Patent Number Company Drug Patent Title Drug Patent Expiry Activity Alert
These drug patents protects the active chemical substance. Only drug patent owner can launch products that use this active substance.
US8114885 NOVARTIS Chemical compounds
Dec, 2021

(2 years ago)

US7262203 NOVARTIS Pyrimidineamines as angiogenesis modulators
Dec, 2021

(2 years ago)

US7105530 NOVARTIS Pyrimidineamines as angiogenesis modulators
Oct, 2023

(6 months ago)

Drug Exclusivity Drug Exclusivity Expiration
Orphan Drug Exclusivity(ODE-23) Apr 26, 2019
New Chemical Entity Exclusivity(NCE) Oct 19, 2014
New Indication(I-649) Apr 26, 2015
Orphan Drug Exclusivity(ODE) Apr 26, 2019

NCE-1 date: 19 October, 2013

Market Authorisation Date: 19 October, 2009

Treatment: NA


More Information on Dosage

VOTRIENT family patents

Family Patents